Biological Emergency Accountability Governance.

1. Introduction

Biological Emergency Accountability Governance is a legal and administrative framework for ensuring that governments, public-health institutions, laboratories, hospitals, pharmaceutical companies and emergency-management authorities act lawfully, transparently, scientifically and responsibly during biological emergencies.

A biological emergency may arise from:

An epidemic or pandemic caused by an infectious disease.

The accidental release of a dangerous pathogen from a laboratory.

A suspected or actual biological attack.

A zoonotic disease transmitted from animals to humans.

Contamination of food, water or biological products.

A public-health emergency involving vaccines, biological medicines or emerging biotechnology.

The central legal question is not merely whether the government possesses emergency powers. It is whether those powers are exercised lawfully, proportionately, transparently and with effective mechanisms for investigating failures and providing remedies to affected people.

In India, this subject is principally connected with the Epidemic Diseases Act, 1897, the Disaster Management Act, 2005, the Constitution of India, applicable environmental and biomedical regulations, and judicial decisions concerning the right to life and public-health administration. A NITI Aayog expert-group report has also identified significant gaps in India's public-health emergency legislation and recommended consideration of a more comprehensive framework.

NITI Aayog

+1

 

An important qualification is that Biological Emergency Accountability Governance is an analytical concept, not the established title of a single Indian statute or a separate, settled judicial doctrine. Its principles must be derived from existing legislation, constitutional law and relevant judicial precedents.

2. Meaning and essential elements

A. Legal accountability

Public authorities must act within statutory powers. Emergency declarations, quarantines, movement restrictions, procurement decisions and enforcement orders must have a lawful basis.

B. Scientific accountability

Decisions should be supported by the best reasonably available evidence, expert advice, risk assessments and appropriate review when scientific knowledge changes.

C. Transparency and disclosure

Authorities should publish relevant emergency orders, public-health guidance, procurement information and aggregate epidemiological data, subject to legitimate privacy, security and confidentiality restrictions.

D. Protection of fundamental rights

Emergency measures must respect human dignity, equality, privacy, bodily integrity and access to essential medical care.

E. Investigation, remedies and institutional learning

Deaths, preventable shortages, laboratory incidents, unlawful discrimination and misuse of emergency funds may require independent investigation, compensation where legally justified, corrective action and reform.

3. Legal framework in India

A. Constitution of India

The Constitution provides the principal standards against which biological emergency decisions are assessed.

Constitutional provisionRelevance
Article 14Protection against arbitrary, irrational or discriminatory state action.
Article 19Restrictions on relevant freedoms must satisfy applicable constitutional requirements.
Article 21Protection of life and personal liberty, including jurisprudential protections relating to health, dignity and bodily integrity.
Article 32Supreme Court remedies for enforcement of fundamental rights.
Article 226High Court writ jurisdiction, including review of unlawful administrative action.
Article 47Directive principle concerning improvement of public health and nutrition.

Articles 32 and 226 are particularly important when emergency powers are exercised arbitrarily, essential treatment is denied, or public authorities fail to discharge legally enforceable duties.

Article 21 does not automatically guarantee every medical intervention or establish government liability for every death. Courts examine the applicable law, the facts, the nature of the state duty and the evidence of the alleged violation.

B. Epidemic Diseases Act, 1897

The Epidemic Diseases Act enables governments to take specified measures to prevent the spread of dangerous epidemic diseases.

Its significance for accountability includes:

Whether the competent authority possessed the necessary statutory power.

Whether the emergency order was properly issued and applied.

Whether restrictions were reasonably related to disease control.

Whether enforcement was discriminatory or excessive.

Whether affected persons had access to judicial review.

The 2020 amendments also introduced specific provisions addressing violence against healthcare service personnel and damage to healthcare property.

A limitation is that the Act is not a complete modern code for every aspect of public-health emergency governance. Official and expert assessments have identified gaps concerning comprehensive preparedness, coordination, surveillance, responsibilities of authorities and citizens' rights.

Ministry of Health and Family Welfare

+1

 

C. Disaster Management Act, 2005

The Disaster Management Act provides a broader framework for disaster planning, coordination, response, relief and recovery.

During COVID-19, the Act was used extensively for national and state-level response measures. It is relevant to:

Coordination among Union, state and district authorities.

Emergency directions and operational planning.

Medical infrastructure and relief arrangements.

Distribution of critical resources.

Disaster-response funding and administrative oversight.

Its emergency powers do not eliminate constitutional review. The existence of a serious biological threat may justify rapid decisions, but does not create unrestricted executive authority.

D. Other relevant laws

Depending on the facts, the following legislation may also apply:

Environment (Protection) Act, 1986: Environmental risks and certain hazardous-substance controls.

Biological Diversity Act, 2002: Relevant biodiversity, access and benefit-sharing questions.

Biomedical Waste Management Rules, 2016: Handling and disposal of regulated biomedical waste.

Drugs and Cosmetics Act, 1940: Applicable regulation of drugs and biological products.

Bio-Medical Research regulations and applicable ICMR guidance: Ethical oversight of relevant biomedical research.

Information Technology Act, 2000 and Digital Personal Data Protection Act, 2023: Potential relevance to digital health information, subject to their scope, commencement and applicable provisions.

These laws have different purposes and do not all apply to every biological emergency. The correct legal framework depends on whether the incident concerns an epidemic, laboratory containment, environmental release, a regulated product, research misconduct or a deliberate attack.

4. Important case laws

The following judgments provide the principal legal foundations for accountability during biological emergencies. Some concern public-health emergencies directly; others establish constitutional principles that can apply by analogy.

Case 1: Paschim Banga Khet Mazdoor Samity v. State of West Bengal (1996)

Supreme Court of India · (1996) 4 SCC 37 · Decided 6 May 1996

Facts: A seriously injured person, Hakim Sheikh, was taken to several government hospitals but did not receive timely admission and treatment.

Issue: Whether failure by state hospitals to provide necessary emergency medical care violated Article 21.

Judgment: The Supreme Court held that failure to provide timely medical treatment in the circumstances violated the patient's right to life. It awarded compensation and directed improvements in emergency medical services.

Indian Kanoon

+1

 

Principle for biological emergency governance:

Governments must maintain functioning emergency medical infrastructure.

Hospital shortages cannot automatically excuse failures to take reasonable measures to preserve life.

Records of treatment, referrals and administrative decisions are important for determining responsibility.

Constitutional remedies and compensation may be available when state action or omission violates fundamental rights.

Application: If a patient suffering from a dangerous infectious disease is repeatedly denied admission because of poor coordination or avoidable administrative failure, this case may support a constitutional challenge, depending on the evidence and circumstances.

Case 2: Jacob Puliyel v. Union of India (2022)

Supreme Court of India · W.P. (C) No. 607 of 2021 · Decided 2 May 2022

Facts: The petitioner challenged aspects of India's COVID-19 vaccination policy, raising questions about vaccine approval, disclosure of clinical-trial information, adverse-event monitoring, bodily autonomy and restrictions affecting unvaccinated persons.

Judgment: The Court recognised bodily integrity and personal autonomy under Article 21 and held that individuals cannot be physically compelled to undergo vaccination. It also recognised that governments may impose reasonable and proportionate public-health restrictions to protect community health. The Court examined the relevant policy and scientific material rather than substituting its own view for expert judgment. It also directed publication of certain clinical-trial findings.

Indian Kanoon

+1

 

Principles established:

Public-health policies remain subject to constitutional review.

Scientific expertise deserves appropriate judicial deference, but does not place government decisions beyond review.

Personal autonomy and community health must be considered together.

Transparency and adverse-event monitoring are important components of accountable vaccination policy.

Application: In a biological emergency involving a new vaccine or biological treatment, authorities should document the scientific basis of their decisions, communicate relevant risks and benefits, and maintain appropriate systems for monitoring adverse events.

The judgment does not establish that every alleged vaccine-related injury is caused by vaccination or that compensation is automatically payable.

Case 3: In Re: Distribution of Essential Supplies and Services During Pandemic (2021)

Supreme Court of India · Suo motu proceedings concerning COVID-19 · Orders in 2021

Background: During the second COVID-19 wave, the Court considered shortages and distribution problems involving medical oxygen and other essential supplies.

Judicial intervention: The proceedings included the creation of a National Task Force to develop a scientific methodology for assessing oxygen requirements, allocating supplies, reviewing distribution and evaluating the need for additional resources.

Indian Kanoon

+1

 

Governance principles:

Emergency resource allocation should be evidence-based.

Allocation decisions should be capable of explanation and review.

Governments need systems to monitor whether essential supplies reach their intended destinations.

Expert-led mechanisms can improve coordination while retaining public accountability.

Application: During an outbreak, authorities should preserve allocation records, assess regional needs, investigate unexplained shortages and establish auditable distribution mechanisms for oxygen, vaccines, medicines and protective equipment.

Case 4: In Re: Proper Treatment of COVID-19 Patients and Dignified Handling of Dead Bodies in Hospitals (2020)

Supreme Court of India · Suo motu proceedings · 2020 INSC 442

Facts: The Court considered reports concerning inadequate treatment of COVID-19 patients and the undignified handling of deceased persons in hospitals.

Judicial response: The Court issued directions addressing the monitoring and supervision of hospitals, patient-care arrangements and the dignified handling of dead bodies. Subsequent proceedings considered additional hospital-safety and COVID-management concerns.

National Digital Library of India

+1

 

Significance:

Emergency conditions do not eliminate the duty to treat patients with dignity.

Hospital administration must be monitored, not merely instructed.

Clear operating procedures and compliance mechanisms are essential.

The treatment of deceased persons and their families remains a matter of legal and ethical concern.

Application: A biological emergency accountability system should include hospital inspections, incident reporting, infection-control audits, patient grievance mechanisms and dignified procedures for handling deaths.

Case 5: Gurusimran Singh Narula v. Union of India (2020)

Supreme Court of India · 2020 INSC 635 · Decided 5 November 2020

Facts: The petitioner sought intervention concerning disinfection tunnels and the spraying of disinfectants on human beings during COVID-19.

Judgment: The Court considered the government's existing advisory against spraying disinfectants on people and observed that authorities should consider appropriate directions to prevent or regulate the practice in light of the health concerns brought to their attention.

National Digital Library of India

 

Accountability principle: Once a competent authority is made aware of a potentially harmful practice that conflicts with its public-health guidance, it should consider whether effective enforcement or further regulation is necessary.

Application: Authorities should act on credible evidence of unsafe emergency interventions, communicate warnings clearly and monitor compliance by public and private institutions.

Case 6: Rachana Gangu v. Union of India (2026)

Supreme Court of India · 2026 INSC 218 · Decided 10 March 2026

Background: The proceedings concerned alleged deaths following COVID-19 vaccination, adverse events following immunisation (AEFI), requests for independent medical examination and demands for compensation.

Judgment: The Supreme Court addressed the state's responsibility to monitor vaccine-related adverse events and directed the Union government to formulate and place in the public domain an appropriate no-fault compensation framework for serious adverse events following COVID-19 vaccination. It also recognised the need for scientific assessment of causation and maintained the distinction between judicial oversight and executive responsibility for policy.

Indian Kanoon

+1

 

Importance for biological emergency accountability:

Adverse-event monitoring should be systematic and accessible.

Serious suspected injuries require appropriate medical and scientific assessment.

Public-health interventions should have fair procedures for considering claims of harm.

A compensation mechanism need not require proof of individual negligence in every eligible case if the applicable no-fault framework provides otherwise.

This is a particularly relevant recent authority. The precise scope of any entitlement depends on the Court's directions and the compensation framework implemented under them; it should not be assumed that every adverse event automatically qualifies.

5. Comparative case-law principles

Legal issueRelevant casePrinciple
Failure to provide emergency treatmentPaschim Banga Khet Mazdoor SamityState hospitals have constitutional duties to provide timely medical care.
Vaccination and personal autonomyJacob PuliyelBodily integrity is protected, while proportionate public-health restrictions may be permissible.
Distribution of scarce suppliesIn Re: Distribution of Essential SuppliesScientific assessment and accountable allocation are important during emergencies.
Hospital treatment and dignityIn Re: Proper Treatment of COVID-19 PatientsMonitoring, adequate care and dignified treatment remain necessary.
Unsafe emergency practicesGurusimran Singh NarulaAuthorities should consider effective action against potentially harmful practices.
Vaccine adverse events and compensationRachana GanguAdverse-event surveillance and an appropriate compensation framework are important state responsibilities.

These judgments do not create one comprehensive doctrine covering every biological emergency. Taken together, however, they support a framework based on constitutional duties, lawful administration, scientific evidence, transparency and remedies for qualifying harm.

6. Who should be held accountable during a biological emergency?

Accountability must be distributed according to the legal duties and actual responsibilities of each institution. A biological emergency may involve several actors, and responsibility should not be attributed to one institution without investigating the evidence.

1. Union and state governments

Responsible for lawful emergency measures, intergovernmental coordination, public communication, preparedness and discharge of applicable statutory and constitutional duties.

2. Public-health and disease-surveillance authorities

Responsible for performing their assigned surveillance, risk-assessment, reporting and outbreak-response functions in accordance with applicable law and protocols.

3. Hospitals and healthcare institutions

Responsible for patient safety, appropriate clinical care, infection prevention, recordkeeping, reporting of relevant incidents and compliance with applicable standards.

4. Laboratories and research institutions

Responsible for applicable biosafety and biosecurity requirements, containment procedures, incident reporting, research ethics and preservation of relevant records.

5. Pharmaceutical and biotechnology companies

Responsible for applicable product-quality requirements, truthful regulatory submissions, pharmacovigilance, required safety disclosures and compliance with marketing authorisations.

6. Independent oversight institutions

Courts, auditors, regulators, legislative committees and other competent oversight bodies may investigate particular failures, review legality and recommend or order appropriate remedies within their respective jurisdictions.

7. Principal legal issues

A. Government negligence and omission

A government may face legal scrutiny when it fails to take reasonable steps required by law to prepare for or respond to a biological emergency.

Examples include:

Failure to maintain legally required emergency-response arrangements.

Unreasonable failure to implement established safety procedures.

Failure to provide emergency medical care where a constitutional or statutory duty applies.

Arbitrary denial of relief or discriminatory distribution of medical resources.

Failure to respond appropriately to credible warnings within the authority's competence.

However, an outbreak or a high death toll does not, by itself, prove government negligence. Courts must consider the applicable duty, available evidence, causation and the circumstances prevailing at the relevant time.

B. Corporate and institutional liability

Private laboratories, manufacturers and hospitals may face regulatory action, civil claims or criminal proceedings when their conduct satisfies the relevant statutory requirements.

For example, a laboratory that negligently breaches an applicable containment obligation and causes injury may face consequences under relevant legislation and ordinary principles of civil or criminal liability.

A pharmaceutical manufacturer may be liable for a defective product or misleading representations where the elements of the applicable legal claim are established.

The existence of a biological emergency does not automatically make every private organisation liable for the consequences of the outbreak.

C. Transparency and access to information

Accountable governance requires appropriate disclosure of:

The legal basis of emergency restrictions.

Public-health orders and reasons for significant decisions.

Relevant scientific assessments and changes in official guidance.

Procurement procedures and emergency expenditure, subject to applicable disclosure rules.

Aggregate disease and adverse-event information.

Findings of authorised investigations.

Confidential patient information, legitimate security interests and protected commercial information may require safeguards. Transparency must be balanced against lawful confidentiality requirements rather than treated as an unrestricted right to access every record.

D. Privacy and biological surveillance

Emergency surveillance may involve sensitive health records, laboratory results, contact-tracing information or genomic data.

A lawful system should define the purpose of collection, limit access, maintain security, establish retention rules and prevent unrelated or discriminatory uses of information.

The constitutional privacy framework in Justice K.S. Puttaswamy (Retd.) v. Union of India (2017), concerning the fundamental right to privacy, is relevant when public authorities introduce extensive health-data collection or surveillance measures.

E. Compensation for victims

Potential remedies depend on the nature of the harm and the applicable legal framework. They may include:

Constitutional compensation for established violations of fundamental rights.

Civil damages where the relevant legal elements are proved.

Statutory compensation under an applicable scheme.

Product-liability remedies where available.

Corrective administrative action and institutional reform.

The distinction between fault-based liability and no-fault compensation is important. A no-fault scheme can provide relief to eligible persons without requiring proof of negligence, subject to the scheme's terms and eligibility criteria.

8. International legal framework

Biological emergencies often cross national borders. International rules therefore complement domestic law.

A. International Health Regulations, 2005

The World Health Organization's International Health Regulations (IHR) establish obligations for participating states concerning public-health risks with potential international implications.

Their relevance includes:

National capacities to detect, assess and report qualifying public-health events.

Communication and coordination with the World Health Organization.

Public-health measures concerning international travel and trade.

Cooperation in responding to international health threats.

The IHR do not replace domestic constitutional safeguards or automatically determine individual compensation claims.

B. Biological Weapons Convention, 1972

The Biological Weapons Convention prohibits the development, production, stockpiling, acquisition and retention of biological agents and toxins for prohibited hostile purposes, together with associated weapons and delivery systems, subject to the Convention's provisions.

It is relevant where a biological emergency involves suspected deliberate misuse rather than an ordinary natural outbreak.

C. International human-rights principles

The right to life, dignity, non-discrimination and applicable protections concerning health and personal autonomy inform how emergency measures should be designed and implemented.

States must reconcile public-health protection with their applicable human-rights obligations. The precise enforceability of an international standard depends on the relevant treaty, domestic law and jurisdiction.

9. A proposed accountability model for biological emergencies

The following is a suggested governance model derived from the principles discussed above, not a claim that Indian law already mandates one unified system.

Stage 1 — Preparedness

Risk assessment, emergency plans, trained personnel, laboratory safety and resource planning.

Stage 2 — Detection and notification

Timely reporting, verification of credible alerts, evidence preservation and risk communication.

Stage 3 — Emergency response

Lawful orders, proportionate restrictions, emergency medical care and transparent allocation of supplies.

Stage 4 — Independent oversight

Compliance audits, incident investigations, judicial review and examination of complaints.

Stage 5 — Remedies and reform

Appropriate compensation, corrective action, public reporting and improvement of future emergency plans.

Suggested performance indicators

An effective system could assess the following indicators:

IndicatorWhat it measures
Detection and notification timeWhether incidents are reported and assessed promptly.
Availability of emergency careWhether affected people can access appropriate treatment.
Resource-allocation transparencyWhether critical supplies are distributed according to defensible criteria.
Incident-investigation completionWhether reported failures receive timely and independent examination.
Adverse-event follow-upWhether suspected treatment- or vaccine-related events receive appropriate assessment.
Complaint and remedy outcomesWhether affected people can access review, relief and corrective action.
Implementation of audit findingsWhether identified institutional failures result in meaningful improvements.

These indicators should be adapted to the type of emergency. For example, a laboratory containment failure requires different technical indicators from a community-wide infectious-disease outbreak.

10. Remedies and enforcement mechanisms

Where a biological emergency reveals unlawful or negligent conduct, possible mechanisms include:

Constitutional remedies: Articles 32 and 226 may permit challenges to unlawful state action, violations of fundamental rights or legally relevant failures to discharge public duties.

Regulatory proceedings: Competent authorities may inspect facilities, require corrective measures, suspend or revoke permissions where authorised, or impose statutory penalties.

Civil proceedings: Injured persons or their representatives may pursue available remedies for negligence, defective products or other legally recognised wrongs.

Criminal proceedings: Criminal liability may arise where the evidence satisfies the elements of an applicable offence, including relevant offences involving negligence, prohibited conduct, falsification or deliberate harmful acts.

Independent investigations: An authorised inquiry may establish the sequence of events, identify institutional failures and recommend preventive changes.

Compensation frameworks: A statutory or administrative scheme may provide relief to eligible victims, particularly where ordinary litigation would be slow or difficult.

None of these mechanisms should be applied automatically. Jurisdiction, evidence, procedural safeguards and the specific legal provisions governing the incident remain decisive.

11. Critical evaluation

The principal challenge in biological emergency governance is balancing speed, scientific uncertainty, public safety and accountability.

Three problems are especially significant.

First, governments may need to act before all scientific questions have been resolved. The legal system should therefore distinguish a reasonable emergency decision based on available evidence from an arbitrary decision or a failure to update an outdated policy.

Second, overlapping statutory powers can create uncertainty about which authority is responsible for a particular task. India's experience during COVID-19, and the subsequent expert-group discussion of public-health legislation, demonstrate the importance of clearly defined duties and coordination arrangements.

NITI Aayog

+1

 

Third, accountability should not become a system of automatic blame. Investigations must distinguish unavoidable scientific uncertainty, resource constraints, individual misconduct, institutional deficiencies and unlawful decisions. A fair system encourages truthful reporting of incidents while preserving meaningful consequences for proven wrongdoing.

A comprehensive framework would ideally specify the powers and duties of each authority, the grounds for emergency declarations, review procedures, minimum standards of care, data-protection safeguards, independent auditing, complaint mechanisms and arrangements for appropriate compensation.

12. Conclusion

Biological Emergency Accountability Governance is a useful framework for understanding the legal responsibilities that arise when disease outbreaks, laboratory incidents or other biological threats endanger human life.

In India, its principal foundations are Article 21 of the Constitution, the Epidemic Diseases Act, 1897, the Disaster Management Act, 2005, other applicable sectoral legislation and judicial decisions.

The cases discussed establish important, though distinct, principles:

Paschim Banga Khet Mazdoor Samity emphasises the state's obligation to provide timely emergency medical treatment.

Jacob Puliyel addresses bodily autonomy, public-health restrictions, scientific decision-making and transparency.

The COVID-19 essential-supplies proceedings illustrate evidence-based allocation and institutional coordination.

The hospital-treatment proceedings emphasise patient dignity and monitoring.

Gurusimran Singh Narula illustrates the importance of responding to potentially harmful emergency practices.

Rachana Gangu highlights adverse-event monitoring and an appropriate compensation framework.

The central legal principle is that emergency powers must be accompanied by clearly defined responsibilities, evidence-based decisions, independent scrutiny and effective remedies. Protecting public health and ensuring governmental accountability are complementary objectives: sound accountability helps institutions identify failures, restore public confidence and prepare more effectively for future biological emergencies.

Academic note: This explanation focuses on Indian law, with international context. For litigation or formal legal citation, the applicable statutory provisions, the complete text of each judgment and any subsequent implementing measures should be verified against authoritative legal sources.

LawGratis provides pro bono legal aid and resources to empower communities. Join us in making justice reachable for everyone! Follow our community on Instagram, YouTube, Facebook, and LinkedIn.

LEAVE A COMMENT